Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1-(p-chlorophenoxy)-1-imidazol-1-yl-3,3-dimethyl-2-butanone
1. 38083-17-9
2. Baypival
3. Climbazol
4. Bay-e 6975
5. Crinipan Ad
6. 1-(4-chlorophenoxy)-1-(1h-imidazol-1-yl)-3,3-dimethylbutan-2-one
7. 2-butanone, 1-(4-chlorophenoxy)-1-(1h-imidazol-1-yl)-3,3-dimethyl-
8. 1-(4-chlorophenoxy)-1-imidazol-1-yl-3,3-dimethylbutan-2-one
9. Nsc-759808
10. 1-(p-chlorophenoxy)-1-imidazol-1-yl-3,3-dimethyl-2-butanone
11. Chebi:83719
12. 1-(4-chlorophenoxy)-1-(1h-imidazol-1-yl)-3,3-dimethyl-2-butanone
13. 9n42cw7i54
14. Ncgc00166153-01
15. Baysan
16. Dsstox_cid_26555
17. Dsstox_rid_81715
18. Dsstox_gsid_46555
19. Climbazolum
20. 1-(4-chlorophenoxy)-1-(1-imidazolyl)-3,3-dimethyl-2-butanone
21. 1-(4-chlorophenoxy)-3,3-dimethyl-1-(imidazole-1-yl)-2-butanone
22. Climbazol [inn-spanish]
23. Climbazolum [inn-latin]
24. Cas-38083-17-9
25. Climbazole [inn:ban]
26. Einecs 253-775-4
27. Brn 0618020
28. Bay E 6975
29. Unii-9n42cw7i54
30. Ccris 8169
31. Meb 6401
32. Mfcd00055505
33. 1-(4-chlorophenoxy)-1-(imidazol-1-yl)-3,3-dimethylbutanone
34. 1-(p-chlorophenoxy)-3,3-dimethyl-1-(1-imidazolyl)-2-butanone
35. Climbazole [inn]
36. Climbazole [inci]
37. (+/-)-climbazole-d4
38. Ec 253-775-4
39. Climbazole [mart.]
40. Climbazole [usp-rs]
41. Climbazole [who-dd]
42. Schembl39729
43. Us9138393, Climbazole
44. Us9144538, Climbazole
45. 5-23-04-00209 (beilstein Handbook Reference)
46. Mls004773943
47. 1-naphthylaceticanhydride
48. Bay E-6975
49. Chembl1437764
50. Dtxsid6046555
51. Owegwhbocfmblp-uhfffaoysa-
52. Bdbm181112
53. Hms2090o13
54. Hms3652p05
55. Hms3744o15
56. Pharmakon1600-01504833
57. 1-(4-chlorophenoxy)-1-(imidazol-1-yl)-3,3-dimethyl-2-butanone
58. 1-(4-clorophenoxy)-3,3-dimethyl-1-(imidazole-1-yl)-2-butanone
59. Hy-b1151
60. Meb-6401
61. Tox21 112343
62. Tox21_112343
63. Ac-272
64. Dl-358
65. Nsc759808
66. S4178
67. 2-butanone, 1-(p-chlorophenoxy)-3,3-dimethyl-1-(1-imidazolyl)-
68. Akos015895513
69. Tox21_112343_1
70. Ccg-213958
71. Cs-4675
72. Db15580
73. Ks-5112
74. Nsc 759808
75. Climbazole 10 Microg/ml In Cyclohexane
76. Ncgc00166153-02
77. Ncgc00166153-03
78. Smr001550495
79. Climbazole 1000 Microg/ml In Acetonitrile
80. Db-049235
81. Ft-0624097
82. Ft-0655760
83. Ft-0665095
84. Sw219213-1
85. Climbazole, Pestanal(r), Analytical Standard
86. H10384
87. Ab01275501-01
88. Ab01275501_02
89. Ab01275501_03
90. 083c179
91. A824009
92. Ao-295/40848554
93. Q629373
94. Sr-05000001501
95. Q-100974
96. Sr-05000001501-1
97. Brd-a61676498-001-01-7
98. Climbazole, United States Pharmacopeia (usp) Reference Standard
99. 1-(4-chloranylphenoxy)-1-imidazol-1-yl-3,3-dimethyl-butan-2-one
100. 1-(4-chlorophenoxy)-1-(imidazol-1-yl)-3,3-dimethylbutan-2-one
101. 1-(4-chlorophenoxy)-3,3-dimethyl-1-(imidazol-1-yl)-butan-2-one
102. (rs)-1-(4-chlorophenoxy)-1-imidazol-1-yl-3,3-dimethylbutan-2-one
Molecular Weight | 292.76 g/mol |
---|---|
Molecular Formula | C15H17ClN2O2 |
XLogP3 | 3.7 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 5 |
Exact Mass | 292.0978555 g/mol |
Monoisotopic Mass | 292.0978555 g/mol |
Topological Polar Surface Area | 44.1 Ų |
Heavy Atom Count | 20 |
Formal Charge | 0 |
Complexity | 335 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Climbazole manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Climbazole, including repackagers and relabelers. The FDA regulates Climbazole manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Climbazole API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Climbazole manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Climbazole supplier is an individual or a company that provides Climbazole active pharmaceutical ingredient (API) or Climbazole finished formulations upon request. The Climbazole suppliers may include Climbazole API manufacturers, exporters, distributors and traders.
click here to find a list of Climbazole suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Climbazole Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Climbazole GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Climbazole GMP manufacturer or Climbazole GMP API supplier for your needs.
A Climbazole CoA (Certificate of Analysis) is a formal document that attests to Climbazole's compliance with Climbazole specifications and serves as a tool for batch-level quality control.
Climbazole CoA mostly includes findings from lab analyses of a specific batch. For each Climbazole CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Climbazole may be tested according to a variety of international standards, such as European Pharmacopoeia (Climbazole EP), Climbazole JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Climbazole USP).
LOOKING FOR A SUPPLIER?